Clinical Trial Update: Efficacy and Safety of add-on Montelukast to Inhaled Budesonide in the Treatment of Nonasthmatic Eosinophilic Bronchitis [Phase 4]

View source ↗

Summary

Phase 4 study evaluating the efficacy and safety of adding montelukast to inhaled budesonide for nonasthmatic eosinophilic bronchitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonasthmatic Eosinophilic Bronchitis

Drugs mentioned

• Budesonide (BUDESONIDE)
• Montelukast (Montelukast)

Snippet

Sponsor: Guangzhou Medical University | Conditions: Nonasthmatic Eosinophilic Bronchitis | Phase 4 | Status: UNKNOWN